摘要
目的:观察治疗慢性盆腔炎中应用替硝唑+盐酸左氧氟沙星的疗效.方法:本次选取100例慢性盆腔炎患者,并在2020年10月-2021年10月按照不同治疗方法分为每组各为50例.其中,对照组为50例(替硝唑治疗),研究组为50例(替硝唑+盐酸左氧氟沙星治疗).比较子宫血流动力学指标水平、盆腔积液深度、淋巴细胞水平、治疗前后的CRP水平、不良反应.结果:研究组的子宫血流动力学指标水平、盆腔积液深度、淋巴细胞水平较对照组改善;治疗前,研究组和对照组在CRP水平方面的对比不存在明显差异性(P ＞ 0.05);治疗后,
Abstract
Objective To observe the efficacy of tenidazole plus levofloxacin hydrochloride in the treatment of chronic pelvic inflammation. Methods: 100 patients with chronic pelvic inflammation were selected and 50 patients from October 2020 to October 2021. Among them, 50 patients were in the control group (tenidazole treatment), and 50 patients were in the study group (tenidazole + levofloxacin hydrochloride treatment). The level of uterine hemodynamic indicators, the depth of pelvic effusions, lymphocytes, CRP levels before and after treatment, and adverse effects were compared. Results: The uterine hemodynamic index level, pelvic fluid depth and lymphocyte level of the study group improved compared with the control group; the CRP level (P＞ 0.05); after treatment, the CRP level of the study group improved and the difference was consistent with P ＜0.05. Conclusion: In the actual treatment of chronic pelvic inflammatory disease, the treatment effect of tenidazole + levofloxacin hydrochloride is remarkable, which can continuously improve the various indicators of patients and avoid the increase of adverse reactions, and it is widely used in clinical practice.
万方数据